ETHZ
ETHZillaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ETHZ
Ethzilla Corporation
Focusing on Ethereum treasury management,enhancing returns through on-chain strategies such as staking and borrowing,and obtaining support from companies like Peter Thiel
Biological Technology
09/07/2016
06/27/2017
NASDAQ Stock Exchange
1
12-31
Common stock
3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA 94306
--
ETHZilla Corporation is a corporation incorporated under the laws of the State of Delaware on September 7, 2016. The company is a clinical-stage biotechnology company that develops novel medicines that meet unmet needs in inflammatory diseases, fibrosis and pain.
Company Financials
EPS
ETHZ has released its 2025 Q3 earnings. EPS was reported at -16.8, versus the expected 0, missing expectations. The chart below visualizes how ETHZ has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ETHZ has released its 2025 Q3 earnings report, with revenue of 4.11M, reflecting a YoY change of NaN%, and net profit of -216.74M, showing a YoY change of -25803.77%. The Sankey diagram below clearly presents ETHZ's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
